BioPharma Asia Convention 2013 post event report now available for download

The 6th annual BioPharma Asia Convention 2013 took place on the 18 – 21 March at Resorts World Sentosa, Singapore. Over 2000 senior level attendees joined us in Singapore last month to meet, network, and discuss latest industry trends, partnership models and investment opportunities in Asia's emerging biopharma industry.

Download post event report

Download sample delegate list

Across the four days of strategic content driven programme and intensive networking sessions, this event saw a total of:

  • Over 800 senior level (directors and above) industry professionals
  • Over 180 speakers
  • More than 2,000 face-to-face meetings were pre-arranged and scheduled onsite
  • More than 200 presentation sessions
  • 76% of attendees from Asia
  • 45% of attendees are President/Chairman/CEO level
  • 36% of attendees from both global and Asian pharma and biotechs
  • Over 50 networking hours
  • Over 39 countries represented

Download the post event report here

Missed out on all the networking opportunities and good fun? No frets!

Book your calendar now for the 7th annual BioPharma Asia Convention 2013, 10 – 13 March, Marina Bay Sands, Singapore

Download the event prospectus here

Visit our website here

Early bird sponsorship and exhibition opportunities available
Contact Rebecca Koh now at +65 6322 2725 or rebecca.koh@terrapinn.com to share with us your business objectives in Asia and let us help you customize an effective participation experience to meet these business needs.

Enquire about speaking opportunities here

Don’t just take our word for it….

"Our experience has been very good. In fact, this is the first time I'm attending the BioPharma Asia conference but I find it very interesting. The morning plenary session was really very interesting and thought provoking. I am participating as a Chairman for the Sustainable Manufacturing programme and it was really interesting to learn more about Singapore's energy management organization and that gave me a lot of new ideas. I think this is a very good opportunity for me."

Sanjit Singh Lamba, President and Managing Director, Eisai, India

"I like it! I think there is more interest in Asia, more development is going on in Asia and Asia is getting wealthier. It is nice to see the positive changes in Asia as well."

Nikolai Tankovich, CEO, Stemedica, USA

"Participation in this conference has really been in line with our objectives of growth in Asia, it allows us to really reach out to a number of our clients. It also allowed us to move forward in a more significant way in terms of making sure that we have a good understanding of where the industry is and what the industry needs."

Lim Bee Koong, Director, Healthcare Strategy, UPS Asia Pacific, Singapore

"This is much larger than our original expectations because we know Singapore is a small country even though I know it is a very active country. But I did not expect so many people came from the different countries. So this is also much exciting and larger conference than expected."

Yoshiya Oda, Unit President, Biomarkers & Personalized Medicine, Eisai, USA

"It's good. The mix of audience that we have here, the delegates and exhibitors have been very good for us. We have been in contact with some of them who have potential business interest in our products so that obviously is a good thing for us as an exhibitor. The logistics and arrangements are also been very well taken care so there is no hassle that we have to go through."

Prashant Bhavaraju, Chief Marketing Officer, Acceliant, USA

"I've had a really good experience hearing from really good speakers. There were good and diversified topics with different speakers coming from different regions not only Asia, but also US and Europe"

Maria D'Orazio, Head of Cold Chain Logistics, Novartis Vaccines & Diagnostics, Italy

"It's been great so far, it's a tremendous meeting. I think that the multiple tracks have made it quite interesting, lots of different colleagues across multiple industries, whether its manufacturing or clinical trials or marketing. It's a really nice way to see all of these colleagues at once. I think that the informational sessions have been great as well."

Kent Thoelke, Executive Vice President, Scientific and Medical Affairs, PRA, USA
We look forward to seeing you in 2014!

Leave a Reply

Your email address will not be published. Required fields are marked *